A row broke out on Friday over a World Health Organisation (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patientโs chances of surviving Covid-19.
A row broke out on Friday over a World Health Organisation (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patientโs chances of surviving Covid-19.
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.
You cannot copy content of this page